Illumina Introduces New Early-Access Capabilities for BioInsight Platform

Illumina, Inc. has launched three new early-access capabilities for its BioInsight Platform, aimed at helping researchers improve their workflows and expedite the transition from data analysis to biological insights. This expansion underscores the company's commitment to enhancing digital and analytical tools for the genomics research community.